CorporateInformation.com
 
Company Search:
Advanced Search
 
Sponsored Links
 
 
 
 
 
 
 
ATGen Company Snapshot
ATGen operates in the Commercial physical research sector. In addition to historical fundamental analyses, the complete report available to purchase compares ATGen with three other companies in this sector in South Korea: SillaJen Inc (2018 sales of 7.71 billion Korean Won [US$6.48 million] of which 54% was Cooperation research development), Panagene Inc (7.70 billion Korean Won [US$6.47 million] ), and Pangen Biotech Inc (5.68 billion Korean Won [US$4.77 million] of which 75% was CMO).

Sales Analysis. ATGen reported sales of 6.27 billion Korean Won (US$5.27 million) for the year ending December of 2018. This represents an increase of 29.8% versus 2017, when the company's sales were 4.83 billion Korean Won. Despite this increase, sales are still below the level achieved in 2016, when ATGen reported sales of 6.88 billion Korean Won.
   
   
 
Company ReportsSubscriptions
 
Looking For More?
Purchace an In-Depth Report
ATGen
  Stock Performance Chart for ATGen
 
  Stock Data: Recent Stock Performance:
  Current Price (11/29/2019): 10,450
(Figures in Korean Won)
1 Week 2.0%   13 Weeks -0.9%  
4 Weeks -1.4%   52 Weeks -24.5%  
 
ATGen Key Data:
  Ticker: 182400 Country: Korea (South)
  Exchanges: SEO Major Industry: Commercial Services & Supplies
    Sub Industry: Commercial Physical Research
  2018 Sales 6,268,827,447
(Year Ending Jan 2019).
Employees: 86
  Currency: Korean Won Market Cap: 326,349,623,050
  Fiscal Yr Ends: December Shares Outstanding: 31,229,629
  Share Type: Common Closely Held Shares: 3,879,392
 
 
 
 
 
Feedback | Terms and Conditions | Privacy Policy | Site Index
 
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.